Lenz Robert A.
SEC CIK 1992908 · EDGAR
BoughtSold
Most active insiders at NBP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hagler Mark Arnold | See Remarks | $577.3K | — |
| 2 | Cao Sean Wuxiong | See Remarks, Dir | — | $122.5K |
| 3 | Xu Cong Claire | SVP, Clinical Development | — | $20.4K |
| 4 | Dennis Phillip Andrew | Chief Medical Off | — | $11.4K |
| 5 | Lenz Robert A. | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-25 16:15 | 2026-08-22 | NBP | NovaBridge Biosciences | Lenz Robert A. | Dir | M - OptEx | — | +17.2K | 17.2K | New | — |
| T | 2025-02-20 | 2025-02-18 | NMRA | Neumora Therapeutics, Inc. | Lenz Robert A. | Head of R, D | S - Sale | $1.67 | -5,614 | 309.1K | -2% | -$9,375 |
| MT | 2024-10-11 | 2024-10-09+ | NMRA | Neumora Therapeutics, Inc. | Lenz Robert A. | Head of R, D | S - Sale | $15.06 | -13.8K | 314.7K | -4% | -$208.1K |
| MT | 2024-09-19 | 2024-09-17+ | NMRA | Neumora Therapeutics, Inc. | Lenz Robert A. | Head of R, D | S - Sale | $11.88 | -41.5K | 339.2K | -11% | -$492.7K |
| T | 2024-09-16 | 2024-09-12 | NMRA | Neumora Therapeutics, Inc. | Lenz Robert A. | Head of R, D | S - Sale | $11.43 | -32.9K | 370.0K | -8% | -$376.6K |
| D | 2024-02-16 | 2024-02-14 | NMRA | Neumora Therapeutics, Inc. | Lenz Robert A. | Head of R, D | A - Grant | $0.00 | +50.0K | 402.9K | +14% | $0 |
| D | 2023-09-18 | 2023-09-14 | NMRA | Neumora Therapeutics, Inc. | Lenz Robert A. | Head of R, D | A - Grant | $0.00 | +352.9K | 352.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations